MGUS Patients Have Higher Hospital Activity Before Diagnosis
Increased hospital activity unrelated to hematology seen for years before diagnosis
Dr. Stephen Hahn Nominated to Head FDA
Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston
CRC Screening Recommended for Average-Risk Adults Age 50 to 75
CRC screening test should be selected based on discussion of benefits, harms, costs with patients
Risk for Second Primary Malignancy Up in CLL Survivors
SPM risk higher for men and nonwhites, after chemotherapy, for recent years of diagnosis, for advanced age
Many Oncologists Fail to Discuss Costs of Genomic Testing
About a quarter of oncologists say they rarely, never bring up costs when they discuss genomic testing
Many Not Receiving Guideline-Concordant Tx for Lung Cancer
Elderly, non-Hispanic blacks particularly less likely to receive recommended lung cancer treatment
October 2019 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2019. This roundup includes...
U.S. Oncologist Shortage May Impact Women’s Health
Major U.S. cities are expected to have a shortage of oncologists
Recommendations Developed to Address Clinician Burnout
Six goals include creation of positive work and learning environments that prevent, reduce burnout
Gilteritinib Superior in Relapsed, Refractory FLT3-Mutated AML
Overall survival significantly longer, percentage of remission higher than with salvage chemotherapy
